hVIVO plc (LON:HVO – Get Free Report) was up 10% during trading on Tuesday . The company traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). Approximately 7,804,669 shares changed hands during trading, an increase of 164% from the average daily volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Performance
The firm’s fifty day moving average price is GBX 20.01 and its 200 day moving average price is GBX 25.58. The firm has a market cap of £129.75 million, a P/E ratio of 635.67 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- Where to Find Earnings Call Transcripts
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- What Makes a Stock a Good Dividend Stock?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What is a Stock Market Index and How Do You Use Them?
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
